Patent Assignment
Reel/Frame 051666/0526
Change of Name
Recorded: 2020-01-22
Pages: 3
Assignor
HENLIUS BIOTECH CO., LTD.
Executed: 2014-12-04
Assignee
HENLIX BIOTECH CO., LTD
5F., NO. 36. LN. 15, SEC. 6 MINQUAN E. RD., TAIPEI, 11494, TAIWAN
Covered Properties
(2)
Anti-Epidermal Growth Factor Receptor (Egfr) Antibodies
Anti-Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Antibodies
Application:
15/740,790 →
Publication:
US 2018/0193456
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 10, 2019
From: HENLIUS BIOPHARMACEUTICALS, INC.
To: HENLIUS BIOTECH CO., LTD
Reel/Frame 051237/0566 →
Assignment of Assignor's Interest
Dec 10, 2019
From: JIANG, WEI-DONG; LIN, PEI-HUA; TSENG, CHI-LING
To: HENLIUS BIOTECH CO., LTD
Reel/Frame 051237/0581 →
Assignment of Assignor's Interest
Dec 10, 2019
From: JIANG, WEI-DONG; LIN, PEI-HUA
To: HENLIUS BIOPHARMACEUTICALS, INC.
Reel/Frame 051244/0737 →
Assignment of Assignor's Interest
Dec 23, 2020
From: HENLIX BIOTECH CO., LTD.
To: SHANGHAI HENLIUS BIOTECH, INC.
Reel/Frame 054743/0862 →